Oxidative stress: Predictive marker for coronary artery disease

Experimental and Clinical Cardiology

Volumn 18, Issue 2, 2013, Pages

  Vichova, Teodora ^a   Motovska, Zuzana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Myocardial infarction; Myocardial remodeling; Oxidative stress; Reactive oxygen species; Reperfusion injury

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DISEASE MARKER; HEART FAILURE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HUMAN; MOLECULAR PATHOLOGY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PREDICTIVE VALUE; RECURRENT DISEASE; REPERFUSION INJURY;

EID: 84879947377     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-66.
2. Misra MK, Sarwat M, Bhakuni P, et al. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009;15:RA209-19.
3. Duilio C, Ambrosio G, Kuppusamy P, et al. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 2001;280:H2649-57.
4. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: The relevance to anesthesia practice. Anesth Analg 2005;101:1275-87.
5. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70:181-90.
6. Cooke MS, Evans MD, Dizdaroglu M, et al. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J 2003;17:1195-214.
7. Varadarajan SG, An J, Novalija E, et al. Changes in [Na(+)](i), compartmental [Ca(2+)], and NADH with dysfunction after global ischemia in intact hearts. Am J Physiol Heart Circ Physiol 2001;280:H280-293.
8. Sun Y. Myocardial repair/remodelling following infarction: Roles of local factors. Cardiovasc Res 2009;81:482-90.
9. Azumi H, Inoue N, Ohashi Y, et al. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: Important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 2002;22:1838-44.
10. Ferrari R, Ceconi C, Curello S, et al. Oxygen free radicals and myocardial damage: Protective role of thiol-containing agents. Am J Med 1991;91:95S-105S.
11. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 2009;81:457-64.
12. Ito H. No-reflow phenomenon in patients with acute myocardial infarction: Its pathophysiology and clinical implications. Acta Med Okayama 2009;63:161-8.
13. Ohoi I, Sone K, Tobari H, et al. A simple chemiluminescence method for measuring oxygen-derived free radicals generated in oxygenated rat myocardium. Jpn J Pharmacol 1993;61:101-7.
14. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51.
15. Okuda M, Inoue N, Azumi H, et al. Expression of glutaredoxin in human coronary arteries: Its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1483-7.
16. Terashima M, Inoue N, Ohashi Y, et al. Relationship between coronary plaque formation and NAD(P)H oxidase-derived reactive oxygen species - comparison of intravascular ultrasound finding of atherosclerotic lesions with histochemical characteristics. Kobe J Med Sci 2007;53:107-17.
17. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem 1988;263:1353-7.
18. Hokamaki J, Kawano H, Soejima H, et al. Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol 2005;99:225-31.
19. Nakamura H, Vaage J, Valen G, et al. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radic Biol Med 1998;24:1176-86.
20. Iuliano L, Praticò D, Greco C, et al. Angioplasty increases coronary sinus F2-isoprostane formation: Evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 2001;37:76-80.
21. Delanty N, Reilly MP, Pratico D, et al. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997;95:2492-9.
22. Feng Y, Shen C, Ma G, et al. Prolonged pain to hospital time is associated with increased plasma advanced oxidation protein products and poor prognosis in patients with percutaneous coronary intervention for ST-elevation myocardial infarction. Heart Vessels 2010;25:374-8.
23. Sigala F, Kotsinas A, Savari P, et al. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. J Vasc Surg 2010;52:704-13.
24. Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-9.
25. Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103:1955-60.
26. Kaneda H, Taguchi J, Ogasawara K, et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002;162:221-5.
27. Miwa K, Kishimoto C, Nakamura H, et al. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol 2003;26:177-81.
28. Ferrari R, Alfieri O, Curello S, et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 1990;81:201-11.
29. Piper HM, García-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300.
30. González-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest 1993;91:456-64.
31. Ferrari R, Guardigli G, Mele D, et al. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des 2004;10:1699-711.
32. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 2002;55:438-455.
33. Naruko T, Ueda M, Ehara S, et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler Thromb Vasc Biol 2006;26:877-83.
34. Nagayoshi Y, Kawano H, Hokamaki J, et al. Urinary 8-hydroxy-2'- deoxyguanosine levels increase after reperfusion in acute myocardial infarction and may predict subsequent cardiac events. Am J Cardiol 2005;95:514-7.
35. Siwik DA, Colucci WS. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 2004;9:43-51.
36. Keith M, Geranmayegan A, Sole MJ, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352-6.
37. Jekell A, Hossain A, Alehagen U, et al. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail 2004;6:883-90.
38. de Meirelles LR, Resende AeC, Matsuura C, et al. Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure. Clin Exp Pharmacol Physiol 2011;38:705-10.
39. Ide T, Tsutsui H, Hayashidani S, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001;88:529-35.
40. Ide T, Tsutsui H, Kinugawa S, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999;85:357-63.
41. Griendling KK, Minieri CA, Ollerenshaw JD, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.
42. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.